PMC:1064895 / 2643-2906
Annnotations
test3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2189 | 119-137 | Protein | denotes | interleukin (IL)-1 |
T2188 | 84-113 | Protein | denotes | tumor necrosis factor (TNF)-α |
T2187 | 70-80 | Negative_regulation | denotes | inhibitors |
T2155 | 119-137 | Protein | denotes | interleukin (IL)-1 |
T2154 | 84-113 | Protein | denotes | tumor necrosis factor (TNF)-α |
R1090 | T2188 | T2187 | themeOf | tumor necrosis factor (TNF)-α,inhibitors |
R1091 | T2189 | T2187 | themeOf | interleukin (IL)-1,inhibitors |
BioNLP16_Messiy
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3714 | 119-137 | Protein | denotes | interleukin (IL)-1 |
T3713 | 84-113 | Protein | denotes | tumor necrosis factor (TNF)-α |
T3746 | 70-80 | Negative_regulation | denotes | inhibitors |
R1776 | T3713 | T3746 | themeOf | tumor necrosis factor (TNF)-α,inhibitors |
R1777 | T3714 | T3746 | themeOf | interleukin (IL)-1,inhibitors |
BioNLP16_DUT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4635 | 70-80 | Negative_regulation | denotes | inhibitors |
T4603 | 119-137 | Protein | denotes | interleukin (IL)-1 |
T4602 | 84-113 | Protein | denotes | tumor necrosis factor (TNF)-α |
R2458 | T4602 | T4635 | themeOf | tumor necrosis factor (TNF)-α,inhibitors |
R2459 | T4603 | T4635 | themeOf | interleukin (IL)-1,inhibitors |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
15642134-12810425-4202008 | 20-21 | 12810425 | denotes | 1 |
biosemtest
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2741 | 250-261 | UMLS/C0302350 | denotes | herapeutic |
T2738 | 84-105 | UP/P13296 | denotes | tumor necrosis factor |
T2734 | 6-12 | UMLS/C0444497 | denotes | joints |
T2717 | 38-46 | UMLS/C0205210 | denotes | clinical |
T2711 | 84-105 | UP/P59694 | denotes | tumor necrosis factor |
T2704 | 84-105 | UP/P19101 | denotes | tumor necrosis factor |
T2697 | 246-249 | UMLS/C0205314 | denotes | ew |
T2692 | 84-105 | UP/O77764 | denotes | tumor necrosis factor |
T2691 | 38-46 | UMLS/C1555900 | denotes | clinical |
T2688 | 84-105 | UP/P51435 | denotes | tumor necrosis factor |
T2678 | 84-105 | UP/Q8MKG8 | denotes | tumor necrosis factor |
T2671 | 84-105 | UP/P59684 | denotes | tumor necrosis factor |
T2664 | 38-46 | UMLS/C1611832 | denotes | clinical |
T2657 | 84-105 | UP/P36939 | denotes | tumor necrosis factor |
T2656 | 84-105 | UP/Q8JFG3 | denotes | tumor necrosis factor |
T2647 | 84-105 | UP/P33620 | denotes | tumor necrosis factor |
T2642 | 84-105 | UP/P79374 | denotes | tumor necrosis factor |
T2637 | 84-105 | UP/Q06599 | denotes | tumor necrosis factor |
T2636 | 84-105 | UP/P59695 | denotes | tumor necrosis factor |
T2635 | 84-105 | UP/P79337 | denotes | tumor necrosis factor |
T2633 | 84-105 | UP/P59693 | denotes | tumor necrosis factor |
T2632 | 84-105 | UP/O35734 | denotes | tumor necrosis factor |
T2624 | 38-46 | UMLS/C1608518 | denotes | clinical |
T2623 | 84-105 | UP/P29553 | denotes | tumor necrosis factor |
T2622 | 84-105 | UP/P23563 | denotes | tumor necrosis factor |
T2621 | 84-105 | UP/Q8HZD9 | denotes | tumor necrosis factor |
T2603 | 168-171 | UMLS/C1554080 | denotes | ey |
T2593 | 6-12 | UMLS/C1706309 | denotes | joints |
T2584 | 84-105 | UP/P23383 | denotes | tumor necrosis factor |
T2575 | 84-105 | UP/Q1G1A2 | denotes | tumor necrosis factor |
T2568 | 84-105 | UP/Q8WNR1 | denotes | tumor necrosis factor |
T2561 | 84-105 | UMLS/C1456820 | denotes | tumor necrosis factor |
T2559 | 84-105 | UP/Q9BEA1 | denotes | tumor necrosis factor |
T2556 | 84-105 | UP/Q19LH4 | denotes | tumor necrosis factor |
T2541 | 246-249 | UMLS/C1553390 | denotes | ew |
T2475 | 56-64 | UMLS/C1706701 | denotes | obtained |
T2474 | 84-105 | UMLS/C2700093 | denotes | tumor necrosis factor |
T2472 | 47-55 | UMLS/C0814225 | denotes | benefits |
T2465 | 84-105 | UP/Q2MH05 | denotes | tumor necrosis factor |
T2464 | 70-80 | UMLS/C1999216 | denotes | inhibitors |
T2463 | 84-105 | UMLS/C0041368 | denotes | tumor necrosis factor |
T2458 | 84-105 | UP/Q539C2 | denotes | tumor necrosis factor |
T2447 | 250-261 | UMLS/C1553525 | denotes | herapeutic |
T2438 | 56-64 | UMLS/C1301820 | denotes | obtained |
T2435 | 231-242 | UMLS/C1527148 | denotes | evelopment |
T2428 | 84-105 | UP/P04924 | denotes | tumor necrosis factor |
T2427 | 84-105 | UP/P01375 | denotes | tumor necrosis factor |
T2420 | 84-105 | UP/P16599 | denotes | tumor necrosis factor |
T2412 | 185-194 | UMLS/C1524094 | denotes | ytokines |
T2403 | 246-249 | UMLS/C1578513 | denotes | ew |
T2395 | 120-131 | UMLS/C0021764 | denotes | nterleukin |
T2381 | 168-171 | UMLS/C1706198 | denotes | ey |
T2372 | 84-105 | UP/P51743 | denotes | tumor necrosis factor |
T2345 | 156-164 | UMLS/C0332206 | denotes | lockade |
T2335 | 84-105 | UMLS/C1323304 | denotes | tumor necrosis factor |
T2333 | 120-131 | UMLS/C1527200 | denotes | nterleukin |
T2332 | 84-105 | UP/O77510 | denotes | tumor necrosis factor |
T2330 | 6-12 | UMLS/C0392905 | denotes | joints |
T2328 | 84-105 | UP/Q75N23 | denotes | tumor necrosis factor |
T2326 | 6-12 | UMLS/C1269611 | denotes | joints |
T2324 | 70-80 | UMLS/C0243077 | denotes | inhibitors |
T2283 | 250-261 | UMLS/C0039796 | denotes | herapeutic |
T2282 | 84-105 | UMLS/C1522668 | denotes | tumor necrosis factor |
T2281 | 139-146 | UMLS/C1705535 | denotes | uggest |
T2533 | 195-198 | UMLS/C2348947 | denotes | as |
T2509 | 6-12 | UMLS/C0022417 | denotes | joints |
T2505 | 84-105 | UP/P06804 | denotes | tumor necrosis factor |
T2493 | 84-105 | UP/Q1WM27 | denotes | tumor necrosis factor |
T2260 | 172-184 | UMLS/C0333348 | denotes | nflammatory |
T2258 | 84-105 | UP/P51742 | denotes | tumor necrosis factor |
T2252 | 250-261 | UMLS/C1547427 | denotes | herapeutic |
T2242 | 185-194 | UMLS/C0079189 | denotes | ytokines |
T2236 | 84-105 | UP/P48094 | denotes | tumor necrosis factor |
pmc-enju-pas
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2975 | 249-260 | JJ | denotes | therapeutic |
T2974 | 245-248 | JJ | denotes | new |
T2973 | 242-244 | IN | denotes | of |
T2972 | 230-241 | NN | denotes | development |
T2971 | 226-229 | DT | denotes | the |
T2970 | 223-225 | IN | denotes | in |
T2969 | 217-222 | NN | denotes | issue |
T2968 | 207-216 | JJ | denotes | important |
T2967 | 203-206 | DT | denotes | the |
T2966 | 198-202 | VB | denotes | been |
T2965 | 194-197 | VB | denotes | has |
T2964 | 184-193 | NN | denotes | cytokines |
T2963 | 171-183 | JJ | denotes | inflammatory |
T2962 | 167-170 | JJ | denotes | key |
T2961 | 164-166 | IN | denotes | of |
T2960 | 155-163 | NN | denotes | blockade |
T2959 | 151-154 | DT | denotes | the |
T2958 | 146-150 | IN | denotes | that |
T2957 | 138-145 | VB | denotes | suggest |
T2956 | 135-137 | CD | denotes | -1 |
T2955 | 134-135 | -RRB- | denotes | ) |
T2954 | 132-134 | NN | denotes | IL |
T2953 | 131-132 | -LRB- | denotes | ( |
T2952 | 119-130 | NN | denotes | interleukin |
T2951 | 115-118 | CC | denotes | and |
T2950 | 113-114 | -RRB- | denotes | ) |
T2949 | 111-113 | NN | denotes | -α |
T2948 | 110-111 | -RRB- | denotes | ) |
T2947 | 107-110 | NN | denotes | TNF |
T2946 | 106-107 | -LRB- | denotes | ( |
T2945 | 99-105 | NN | denotes | factor |
T2944 | 90-98 | NN | denotes | necrosis |
T2943 | 84-89 | NN | denotes | tumor |
T2942 | 81-83 | IN | denotes | of |
T2941 | 70-80 | NN | denotes | inhibitors |
T2940 | 65-69 | IN | denotes | with |
T2939 | 56-64 | VB | denotes | obtained |
T2938 | 47-55 | NN | denotes | benefits |
T2937 | 38-46 | JJ | denotes | clinical |
T2936 | 28-37 | JJ | denotes | favorable |
T2935 | 24-27 | DT | denotes | The |
T2934 | 21-22 | -RRB- | denotes | ] |
T2933 | 20-21 | CD | denotes | 1 |
T2932 | 19-20 | -LRB- | denotes | [ |
T2931 | 16-18 | NN | denotes | RA |
T2930 | 13-15 | IN | denotes | in |
T2929 | 6-12 | NN | denotes | joints |
T2928 | 3-5 | IN | denotes | of |
R1191 | T2929 | T2928 | arg2Of | joints,of |
R1192 | T2931 | T2930 | arg2Of | RA,in |
R1193 | T2933 | T2932 | arg2Of | 1,[ |
R1194 | T2934 | T2932 | arg3Of | ],[ |
R1195 | T2938 | T2935 | arg1Of | benefits,The |
R1196 | T2938 | T2936 | arg1Of | benefits,favorable |
R1197 | T2938 | T2937 | arg1Of | benefits,clinical |
R1198 | T2938 | T2939 | arg2Of | benefits,obtained |
R1199 | T2938 | T2950 | arg1Of | benefits,) |
R1200 | T2938 | T2951 | arg1Of | benefits,and |
R1201 | T2939 | T2940 | arg1Of | obtained,with |
R1202 | T2941 | T2940 | arg2Of | inhibitors,with |
R1203 | T2941 | T2942 | arg1Of | inhibitors,of |
R1204 | T2945 | T2943 | arg1Of | factor,tumor |
R1205 | T2945 | T2944 | arg1Of | factor,necrosis |
R1206 | T2945 | T2946 | arg1Of | factor,( |
R1207 | T2947 | T2946 | arg2Of | TNF,( |
R1208 | T2948 | T2946 | arg3Of | ),( |
R1209 | T2949 | T2942 | arg2Of | -α,of |
R1210 | T2949 | T2945 | arg1Of | -α,factor |
R1211 | T2951 | T2957 | arg1Of | and,suggest |
R1212 | T2952 | T2951 | arg2Of | interleukin,and |
R1213 | T2952 | T2953 | arg1Of | interleukin,( |
R1214 | T2952 | T2956 | arg1Of | interleukin,-1 |
R1215 | T2954 | T2953 | arg2Of | IL,( |
R1216 | T2955 | T2953 | arg3Of | ),( |
R1217 | T2960 | T2959 | arg1Of | blockade,the |
R1218 | T2960 | T2961 | arg1Of | blockade,of |
R1219 | T2960 | T2965 | arg1Of | blockade,has |
R1220 | T2960 | T2966 | arg1Of | blockade,been |
R1221 | T2964 | T2961 | arg2Of | cytokines,of |
R1222 | T2964 | T2962 | arg1Of | cytokines,key |
R1223 | T2964 | T2963 | arg1Of | cytokines,inflammatory |
R1224 | T2966 | T2957 | arg2Of | been,suggest |
R1225 | T2966 | T2958 | arg1Of | been,that |
R1226 | T2966 | T2965 | arg2Of | been,has |
R1227 | T2966 | T2970 | arg1Of | been,in |
R1229 | T2969 | T2966 | arg2Of | issue,been |
R1230 | T2969 | T2967 | arg1Of | issue,the |
R1231 | T2969 | T2968 | arg1Of | issue,important |
R1232 | T2972 | T2970 | arg2Of | development,in |
R1233 | T2972 | T2971 | arg1Of | development,the |
R1234 | T2972 | T2973 | arg1Of | development,of |
bionlp-st-ge-2016-coref
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3464 | 119-137 | Antecedent | denotes | interleukin (IL)-1 |
T3463 | 84-113 | Antecedent | denotes | tumor necrosis factor (TNF)-α |
T3462 | 167-193 | Anaphor | denotes | key inflammatory cytokines |
R1726 | T3462 | T3463 | boundBy | key inflammatory cytokines,tumor necrosis factor (TNF)-α |
R1728 | T3462 | T3464 | boundBy | key inflammatory cytokines,interleukin (IL)-1 |
bionlp-st-ge-2016-test-proteins
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3483 | 119-137 | Protein | denotes | interleukin (IL)-1 |
T3482 | 84-113 | Protein | denotes | tumor necrosis factor (TNF)-α |
bionlp-st-ge-2016-uniprot
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3688 | 107-113 | http://www.uniprot.org/uniprot/P01375 | denotes | TNF)-α |
T3686 | 107-110 | http://www.uniprot.org/uniprot/P01375 | denotes | TNF |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2770 | 230-241 | http://purl.obolibrary.org/obo/GO_0032502 | denotes | development |
T2769 | 90-98 | http://purl.obolibrary.org/obo/GO_0070265 | denotes | necrosis |
T2768 | 90-98 | http://purl.obolibrary.org/obo/GO_0019835 | denotes | necrosis |
T2767 | 90-98 | http://purl.obolibrary.org/obo/GO_0008219 | denotes | necrosis |
T2766 | 90-98 | http://purl.obolibrary.org/obo/GO_0001906 | denotes | necrosis |
GO-MF
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3515 | 132-137 | http://purl.obolibrary.org/obo/GO_0005149 | denotes | IL)-1 |
simple1
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3654 | 119-137 | Protein | denotes | interleukin (IL)-1 |
T3653 | 84-113 | Protein | denotes | tumor necrosis factor (TNF)-α |
DLUT931
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3795 | 70-80 | Negative_regulation | denotes | inhibitors |
T3763 | 119-137 | Protein | denotes | interleukin (IL)-1 |
T3762 | 84-113 | Protein | denotes | tumor necrosis factor (TNF)-α |
R1780 | T3762 | T3795 | themeOf | tumor necrosis factor (TNF)-α,inhibitors |
R1782 | T3763 | T3795 | themeOf | interleukin (IL)-1,inhibitors |
bionlp-st-ge-2016-test-ihmc
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4581 | 70-113 | Entity | denotes | inhibitors of tumor necrosis factor (TNF)-α |
T4567 | 84-113 | Protein | denotes | tumor necrosis factor (TNF)-α |
T4558 | 171-193 | Protein | denotes | inflammatory cytokines |
T4525 | 119-137 | Protein | denotes | interleukin (IL)-1 |
T4521 | 16-18 | Protein | denotes | RA |
bionlp-st-ge-2016-spacy-parsed
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3937 | 249-260 | JJ | denotes | therapeutic |
T3936 | 245-248 | JJ | denotes | new |
T3935 | 242-244 | IN | denotes | of |
T3934 | 230-241 | NN | denotes | development |
T3933 | 226-229 | DT | denotes | the |
T3932 | 223-225 | IN | denotes | in |
T3931 | 217-222 | NN | denotes | issue |
T3930 | 207-216 | JJ | denotes | important |
T3929 | 203-206 | DT | denotes | the |
T3928 | 198-202 | VBN | denotes | been |
T3927 | 194-197 | VBZ | denotes | has |
T3926 | 184-193 | NNS | denotes | cytokines |
T3925 | 171-183 | JJ | denotes | inflammatory |
T3924 | 167-170 | JJ | denotes | key |
T3923 | 164-166 | IN | denotes | of |
T3922 | 155-163 | NN | denotes | blockade |
T3921 | 151-154 | DT | denotes | the |
T3920 | 146-150 | IN | denotes | that |
T3919 | 138-145 | VBP | denotes | suggest |
T3918 | 135-137 | CD | denotes | -1 |
T3917 | 134-135 | -RRB- | denotes | ) |
T3916 | 132-134 | NNP | denotes | IL |
T3915 | 131-132 | -LRB- | denotes | ( |
T3914 | 119-130 | NN | denotes | interleukin |
T3913 | 115-118 | CC | denotes | and |
T3912 | 113-114 | -RRB- | denotes | ) |
T3911 | 112-113 | VBN | denotes | α |
T3910 | 111-112 | : | denotes | - |
T3909 | 110-111 | -RRB- | denotes | ) |
T3908 | 107-110 | NNP | denotes | TNF |
T3907 | 106-107 | -LRB- | denotes | ( |
T3906 | 99-105 | NN | denotes | factor |
T3905 | 90-98 | NN | denotes | necrosis |
T3904 | 84-89 | NN | denotes | tumor |
T3903 | 81-83 | IN | denotes | of |
T3902 | 70-80 | NNS | denotes | inhibitors |
T3901 | 65-69 | IN | denotes | with |
T3900 | 56-64 | VBN | denotes | obtained |
T3899 | 47-55 | NNS | denotes | benefits |
T3898 | 38-46 | JJ | denotes | clinical |
T3897 | 28-37 | JJ | denotes | favorable |
T3896 | 24-27 | DT | denotes | The |
T3895 | 22-23 | . | denotes | . |
T3894 | 21-22 | NNP | denotes | ] |
T3893 | 20-21 | CD | denotes | 1 |
T3892 | 19-20 | NNP | denotes | [ |
T3891 | 16-18 | NNP | denotes | RA |
T3890 | 13-15 | IN | denotes | in |
T3889 | 6-12 | NNS | denotes | joints |
T3888 | 3-5 | IN | denotes | of |
R1922 | T3889 | T3888 | pobj | joints,of |
R1925 | T3891 | T3892 | compound | RA,[ |
R1929 | T3892 | T3890 | pobj | [,in |
R1934 | T3893 | T3894 | nummod | 1,] |
R1939 | T3894 | T3892 | appos | ],[ |
R1947 | T3896 | T3899 | det | The,benefits |
R1951 | T3897 | T3899 | amod | favorable,benefits |
R1955 | T3898 | T3899 | amod | clinical,benefits |
R1958 | T3899 | T3911 | nsubj | benefits,α |
R1962 | T3900 | T3899 | acl | obtained,benefits |
R1966 | T3901 | T3900 | prep | with,obtained |
R1969 | T3902 | T3901 | pobj | inhibitors,with |
R1973 | T3903 | T3902 | prep | of,inhibitors |
R1977 | T3904 | T3905 | compound | tumor,necrosis |
R1983 | T3905 | T3906 | compound | necrosis,factor |
R1984 | T3906 | T3903 | pobj | factor,of |
R1985 | T3907 | T3908 | punct | (,TNF |
R1988 | T3908 | T3906 | appos | TNF,factor |
R1990 | T3909 | T3900 | punct | ),obtained |
R1993 | T3910 | T3899 | punct | -,benefits |
R1997 | T3911 | T3911 | ROOT | α,α |
R2000 | T3912 | T3911 | punct | ),α |
R2004 | T3913 | T3911 | cc | and,α |
R2008 | T3914 | T3919 | nsubj | interleukin,suggest |
R2012 | T3915 | T3916 | punct | (,IL |
R2015 | T3916 | T3914 | appos | IL,interleukin |
R2019 | T3917 | T3918 | punct | ),-1 |
R2023 | T3918 | T3919 | nsubj | -1,suggest |
R2026 | T3919 | T3911 | conj | suggest,α |
R2033 | T3920 | T3928 | mark | that,been |
R2037 | T3921 | T3922 | det | the,blockade |
R2041 | T3922 | T3928 | nsubj | blockade,been |
R2045 | T3923 | T3922 | prep | of,blockade |
R2048 | T3924 | T3926 | amod | key,cytokines |
R2052 | T3925 | T3926 | amod | inflammatory,cytokines |
R2056 | T3926 | T3923 | pobj | cytokines,of |
R2060 | T3927 | T3928 | aux | has,been |
R2064 | T3928 | T3919 | ccomp | been,suggest |
R2068 | T3929 | T3931 | det | the,issue |
R2071 | T3930 | T3931 | amod | important,issue |
R2075 | T3931 | T3928 | attr | issue,been |
R2079 | T3932 | T3931 | prep | in,issue |
R2081 | T3933 | T3934 | det | the,development |
R2084 | T3934 | T3932 | pobj | development,in |
R2087 | T3935 | T3934 | prep | of,development |
bionlp-st-ge-2016-test-tees
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3604 | 70-80 | Negative_regulation | denotes | inhibitors |
T3603 | 70-80 | Negative_regulation | denotes | inhibitors |
T3602 | 119-137 | Protein | denotes | interleukin (IL)-1 |
T3601 | 84-113 | Protein | denotes | tumor necrosis factor (TNF)-α |
R1751 | T3601 | T3603 | themeOf | tumor necrosis factor (TNF)-α,inhibitors |
R1753 | T3602 | T3604 | themeOf | interleukin (IL)-1,inhibitors |
testone
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2108 | 119-137 | Protein | denotes | interleukin (IL)-1 |
T2107 | 84-113 | Protein | denotes | tumor necrosis factor (TNF)-α |